Skip to main content

and
  1. Article

    Open Access

    Selective haematological cancer eradication with preserved haematopoiesis

    Haematopoietic stem cell (HSC) transplantation (HSCT) is the only curative treatment for a broad range of haematological malignancies, but the standard of care relies on untargeted chemotherapies and limited p...

    Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage in Nature (2024)

  2. Article

    Open Access

    Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

    Tumor-specific T cells are frequently exhausted by chronic antigenic stimulation. We here report on a human antigen-specific ex vivo model to explore new therapeutic options for T cell immunotherapies. T cells...

    Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur in Nature Communications (2023)

  3. Article

    Open Access

    FOXO1 gene involvement in a non-rhabdomyosarcomatous neoplasm

    Myoepithelial neoplasms of soft tissue are rare tumors with clinical, morphological, immunohistochemical, and genetic heterogeneity. The morphological spectrum of these tumors is broad, and the diagnosis often...

    Simon Haefliger, Muriel Genevay, Michel Bihl, Romina Marone in Virchows Archiv (2021)

  4. No Access

    Protocol

    Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells

    The CRISPR/Cas technology allows for genome editing in primary T cells. We herein describe the activation of primary murine CD4+ or CD8+ T cells, followed by electroporation with plasmid or ribonucleoproteins (RN...

    Marianne Dölz, Romina Marone, Lukas T. Jeker in T-Helper Cells (2021)

  5. No Access

    Article

    Inactivation of a Gαs–PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis

    Genomic alterations in GNAS, the gene coding for the Gαs heterotrimeric G protein, are associated with a large number of human diseases. Here, we explored the role of Gαs on stem cell fate decisions by using the ...

    Ramiro Iglesias-Bartolome, Daniela Torres, Romina Marone in Nature Cell Biology (2015)

  6. No Access

    Article

    Targeting PI3K in neuroblastoma

    This work employs pharmacological targeting of phosphoinositide 3-kinases (PI3K) in selected neuroblastoma (NB) tumors with the inhibitor AS605240, which has been shown to express low toxicity and relative spe...

    Volker Spitzenberg, Christian König in Journal of Cancer Research and Clinical On… (2010)

  7. No Access

    Article

    Memo mediates ErbB2-driven cell motility

    Clinical studies have revealed that cancer patients whose tumours have increased ErbB2 expression tend to have more aggressive, metastatic disease, which is associated with parameters predicting a poor outcome1,2

    Romina Marone, Daniel Hess, David Dankort, William J. Muller in Nature Cell Biology (2004)